ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
CAMBRIDGE, Massachusetts and TORONTO, Ontario, March 11, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a biotechnology comp...
Stay updated with breaking news from Collective Coordinates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAMBRIDGE, Massachusetts and TORONTO, Ontario, March 11, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a biotechnology comp...
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will present at the 2024 BIO CEO & Investor Conference, taking place in-person in New York, NY on February 26-27, 2024. Presentation Details: Presen
ProMIS Neurosciences, Inc. (TSE:PMN – Get Free Report) shares traded down 3.8% during mid-day trading on Monday . The company traded as low as C$5.98 and last traded at C$6.00. 19,701 shares changed hands during trading, an increase of 492% from the average session volume of 3,327 shares. The stock had previously closed at C$6.24. […]
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Nov. 20, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology compan...
ProMIS Neurosciences Inc. , a clinical-stage biotechnology company focused on the...